CD40 Signaling and Plaque Instability
Authors
Discussion
Loading...
Member takes
Implication
Randomized trial illustrates CD40 signaling's impact on plaque stability in atherosclerosis, indicating its role as a therapeutic target.
Key Points
- This research investigates the role of CD40 signaling in atherogenesis and its influence on plaque stability.
- In vitro studies evaluated CD40 ligation effects on endothelial cells, smooth muscle cells, and macrophages.
- Assessment of proatherogenic responses triggered by CD40 signaling on various cell types.
- Comparison of outcomes from CD40/CD40L interruption in mouse models of atherosclerosis.
- Interruption of CD40/CD40L interactions reduced atheroma formation and progression in mouse models.
- Ligation of CD40 increased expression of pro-inflammatory cytokines and matrix metalloproteinases in cell cultures.
- Findings support that CD40/CD40L interactions can destabilize atherosclerotic plaques.
Cite This Study
Schönbeck et al. (2001) studied this question.